As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...

Another preventive measure is monoclonal antibodies — artificially created proteins that can be given to infants to assist ...

It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new monoclonal antibody ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric respiratory syncytial virus (RSV) infections in China. Addressing 12 clinical ...

Only a small percentage—10.4%—was nonfrail. Severe RSV Outcomes The researchers found that severe cases of RSV were more common among patients aged 75 to 84 years (27.4%) and 85 years and older (27.7% ...

Three Cases of Vertical Transmission of Clade Ib Mpox Virus Published June 18, 2025 N Engl J Med 2025;392: 2385 - 2387 DOI: 10.1056/NEJMc2503347 ...

FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59 The extension of the shot’s approval is a welcome win for company after recent setbacks Bill Sikes/AP By Helen Branswell June ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young children, placing a significant burden on families, hospitals, and the healthcare system. Recent ...